Literature DB >> 1641592

Prevalence of Mycoplasma pneumoniae in subjectively healthy individuals.

J Gnarpe1, A Lundbäck, B Sundelöf, H Gnarpe.   

Abstract

Subjectively healthy persons were investigated for the presence of Mycoplasma pneumoniae in throat cultures. During a peak period of M. pneumoniae incidence, 13.5% of 758 healthy volunteers were found to harbour the bacterium in the throat. The investigation was continued, and during a subsequent period of 11 months, the incidence of M. pneumoniae isolated decreased to 4.6% of 499 volunteers. All new blood donor sera 1990-1991 (422 sera) were screened for the presence of antibodies to M. pneumoniae; it was found that there was a fluctuating but significant number of individuals with positive serology based on a single test occasion.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1641592     DOI: 10.3109/00365549209052607

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  29 in total

1.  Rationalised prescribing for community acquired pneumonia: a closed loop audit.

Authors:  H Clements; T Stephenson; V Gabriel; T Harrison; M Millar; A Smyth; W Tong; C J Linton
Journal:  Arch Dis Child       Date:  2000-10       Impact factor: 3.791

Review 2.  Molecular diagnosis of Mycoplasma pneumoniae respiratory tract infections.

Authors:  K Loens; D Ursi; H Goossens; M Ieven
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

3.  Resistance to antimicrobial peptides and stress response in Mycoplasma pulmonis.

Authors:  Lina Fassi Fehri; Pascal Sirand-Pugnet; Géraldine Gourgues; Gwenaël Jan; Henri Wróblewski; Alain Blanchard
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

4.  Molecular approaches to diagnosis of pulmonary diseases due to Mycoplasma pneumoniae.

Authors:  M Abele-Horn; U Busch; H Nitschko; E Jacobs; R Bax; F Pfaff; B Schaffer; J Heesemann
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

5.  Clinical severity of Mycoplasma pneumoniae (MP) infection is associated with bacterial load in oropharyngeal secretions but not with MP genotype.

Authors:  Anna C Nilsson; Per Björkman; Christina Welinder-Olsson; Anders Widell; Kenneth Persson
Journal:  BMC Infect Dis       Date:  2010-02-25       Impact factor: 3.090

6.  Evaluation of five real-time PCR assays for detection of Mycoplasma pneumoniae.

Authors:  Roger Dumke; Enno Jacobs
Journal:  J Clin Microbiol       Date:  2014-09-10       Impact factor: 5.948

7.  Mycoplasma pneumoniae detection causes excess antibiotic use in Norwegian general practice: a retrospective case-control study.

Authors:  Mats Foshaug; Maria Vandbakk-Rüther; Dagfinn Skaare; Nils Grude; Morten Lindbæk
Journal:  Br J Gen Pract       Date:  2015-02       Impact factor: 5.386

Review 8.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

9.  Are outbreaks and sporadic respiratory infections by Mycoplasma pneumoniae due to two distinct subtypes?

Authors:  E Jacobs; M Vonski; K Oberle; O Opitz; K Pietsch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-01       Impact factor: 3.267

10.  Mycoplasma pneumonia: Clinical features and management.

Authors:  Surender Kashyap; Malay Sarkar
Journal:  Lung India       Date:  2010-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.